The new class of the human ASK1 inhibitors has been identified by our scientists
Friday, 04 March 2011
Apoptosis signal-regulating kinase 1 (ASK1) has recently emerged as an attractive therapeutic target for the treatment of cardiac and neurodegenerative disorders. The selective inhibitors...
The new class of potent ATP-competitive inhibitors of the human protein kinase CK2 has been identified
Tuesday, 22 February 2011
A novel series of substituted (thieno[2,3-d]pyrimidin-4-ylthio)carboxylic acids has been synthesized and tested in vitro towards human protein kinase CK2. It was revealed that the...
Scientists from Department of Medicinal Chemistry participated in the VI International Conference on Protein Kinase CK2 (07-10 September, 2010, Cologne, Germany). Their oral presentation...